Journal article
Feline immunodeficiency virus vectors persistently transduce nondividing airway epithelia and correct the cystic fibrosis defect
The Journal of clinical investigation, Vol.104(11), pp.R55-R62
12/01/1999
DOI: 10.1172/JCI8390
PMCID: PMC483477
PMID: 10587528
Abstract
Several problems limit the application of gene transfer to correct the cystic fibrosis (CF) Cl
–
transport defect in airway epithelia. These include inefficient transduction with vectors applied to the apical surface, a low rate of division by airway epithelial cells, failure of transgene expression to persist, and immune responses to vectors or vector-encoded proteins. To address these issues, we used a feline immunodeficiency virus–based (FIV-based) vector. FIV vector formulated with a calcium chelator transduced fully differentiated, nondividing human airway epithelia when applied to the apical surface. FIV-based vector encoding the cystic fibrosis transmembrane conductance regulator cDNA corrected the Cl
–
transport defect in differentiated CF airway epithelia for the life of the culture (>3 months). When this approach was applied in vivo, FIV vector expressing β-galactosidase transduced 1–14% of adult rabbit airway epithelia. Transduced cells were present in the conducting airways, bronchioles, and alveoli. Importantly, gene expression persisted, and cells with progenitor capacity were targeted. FIV-based lentiviral vectors may be useful for the treatment of genetic lung diseases such as CF.
This article may have been published online in advance of the print edition. The date of publication is available from the JCI website, http://www.jci.org.
J. Clin. Invest.
104
:R55–R62 (1999).
Details
- Title: Subtitle
- Feline immunodeficiency virus vectors persistently transduce nondividing airway epithelia and correct the cystic fibrosis defect
- Creators
- Guoshun Wang - Program in Gene Therapy, Department of Pediatrics, andVladimir Slepushkin - Program in Gene Therapy, Department of Pediatrics, andJoseph Zabner - Program in Gene Therapy, Department of Pediatrics, andShaf Keshavjee - Program in Gene Therapy, Department of Pediatrics, andJulie C Johnston - Program in Gene Therapy, Department of Pediatrics, andSybille L Sauter - Program in Gene Therapy, Department of Pediatrics, andDoug J Jolly - Program in Gene Therapy, Department of Pediatrics, andThomas W Dubensky - Program in Gene Therapy, Department of Pediatrics, andBeverly L Davidson - Program in Gene Therapy, Department of Pediatrics, andPaul B McCray - Program in Gene Therapy, Department of Pediatrics, and
- Resource Type
- Journal article
- Publication Details
- The Journal of clinical investigation, Vol.104(11), pp.R55-R62
- Publisher
- American Society for Clinical Investigation
- DOI
- 10.1172/JCI8390
- PMID
- 10587528
- PMCID
- PMC483477
- ISSN
- 0021-9738
- eISSN
- 1558-8238
- Language
- English
- Date published
- 12/01/1999
- Academic Unit
- Pulmonary, Critical Care, and Occupational Medicine; Microbiology and Immunology; Pulmonary Medicine; Stead Family Department of Pediatrics; Internal Medicine
- Record Identifier
- 9984093338702771
Metrics
18 Record Views